Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-02-25
1996-01-02
Wityshyn, Michael G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 21, 514 23, 424418, 424439, 426 72, 426656, 426658, A61K 3100, A23J 100
Patent
active
054808650
ABSTRACT:
Nutritional compositions are provided for the management of protein intake which have a carbohydrate to protein ratio of at least about 3.5:1 and a ratio of one group of amino acids to another group of amino acids of from about 3:1 to about 6.5:1 where the one group consists of glycine, serine, lysine, alanine, aspartic acid, glutamic acid, proline, arginine and hydroxyproline and the other group of amino acids consists of phenylalanine, tryptophan, threonine, valine, isoleucine, histidine, leucine, tyrosine and methionine. The compositions provide minimized interference with large neutral amino acid (LNAA) type therapeutic agents.
REFERENCES:
patent: 4377595 (1983-03-01), Wurtman
patent: 4435424 (1984-03-01), Wurtman
patent: 4542123 (1985-09-01), Wurtman
patent: 4624852 (1986-11-01), Wurtman
patent: 4690820 (1987-09-01), Simko
patent: 4737489 (1988-04-01), Wurtman
patent: 4775665 (1988-10-01), Wurtman
patent: 4837219 (1989-06-01), Hutterer
patent: 4898879 (1990-02-01), Modser et al.
patent: 5096712 (1992-03-01), Wurtman
patent: 5118670 (1992-06-01), Wurtman et al.
patent: 5206218 (1993-04-01), Wurtman et al.
patent: 5326569 (1994-07-01), Acosta et al.
Olendorf, W. H. "Brain Uptake of Radiolabeled Amino Acids, Amines, and Hexones After Arterial Injection", Am J. Physiol. (1971) 221: 1629-1639.
Leenders, K. L. et al., "Inhibition of L-18F-Flurodopa Uptake Into Human Brain by Amino Acids . . . Tomography". Ann. Neurol. (1986) 20: 258-262.
Nutt, J. G. On-Off phenomenon: "Relation to Levodopa Pharmacokinetics and Pharmacodynamics", Ann. Neurol. (1987) 22: 535-540.
Piucus, J. et al., "Influence of Dietary Protein on Motor Fluctuations in Parkinson's Disease". Arch. Neorol. (1987) 44: 270-272.
Pincus, J. et al., "Plasma Levels of Amino Acids Correlate with Motor Fluctations in Parkinsonism". Arch. Neurol. (1987) 44: 1006-1009.
Pincus, "Protein Redistribution Diet Restores Motor Function . . . Patients with Dopa-Resistant off" Periods. Neurol. (1988) 38:481-483.
Yen, P. K., "Does a Low-Protein Diet Help with Parkinson's?" Geriatric Nursing (1990) (Jan./Feb.) 48.
Nutt, J. G. et al., "Dietary . . . of Parkinson's Disease", Ch. 28 in Therapy . . . Disease, edited by W. C. Koller and G. Paulson, (1990) Decker Press, N.Y.
F. Bracco et al., "Protein Redistribution Diet and Antiparkinsonian Response to Levodopa", Eur. Neurol. (1991) 31: 68-71.
Karstaedt, P. J. et al., "Standard and Controlled-Release . . . Disease on a Protein Redistribution Diet" Arch Neurol. (1991) 48: 402-405.
Croxson, S. et al., "Dietary Modification of Parkinson's Disease". European Journal of Clinical Nutrition (1991) 45: 263-266.
Berry, E. M. et al., "A Balanced Carbohydrate: Protein Diet in the Management of Parkinson's Disease" Neurology (1991) 41: 1295-1297.
Cerrato, P. L., "Diet Therapy Helps This Drug Work Better" RN (1991) 54(2): 71-2, 74.
Kempster, P. A. et al., "Dietary Factors in the Management of Parkinson's Disease", Nutritional Reviews (1994) 52: 51-58.
Mohamed Abdel A.
Parkinson's Charitable Trust
Wityshyn Michael G.
LandOfFree
Nutritional composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nutritional composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nutritional composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-235188